DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
NCT00362882
Drugs and interventions used in this trial
6 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
bortezomib
Normalized identity: bortezomibView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
immunoenzyme technique
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
immunohistochemistry staining method
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
pharmacological study
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedDocetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
bortezomibDRUG · verified · RxNorm: bortezomib
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00362882 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.